Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Iterum Therapeutics

    NASDAQ: ITRM · Real-Time Price · USD
    0.94
    -0.03 (-2.89%)
    At close: Jul 03, 2025, 12:23 PM

    Iterum Therapeutics Statistics

    Share Statistics

    Iterum Therapeutics has 40M shares outstanding. The number of shares has increased by 76.16% in one year.

    Shares Outstanding

    n/a
    		 40M

    Shares Change (YoY)

    n/a
    		 76.16%

    Shares Change (QoQ)

    n/a
    		 15.67%

    Owned by Institutions (%)

    n/a
    		 0.3%

    Shares Floating

    n/a
    		 39.13M

    Failed to Deliver (FTD) Shares

    n/a
    		 6,527

    FTD / Avg. Volume

    n/a
    		 1.23%

    Short Selling Information

    The latest short interest is 1.17M, so 2.92% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.17M

    Short % of Shares Out

    n/a
    		 2.92%

    Short % of Float

    n/a
    		 2.98%

    Short Ratio (days to cover)

    n/a
    		 2.54

    Valuation Ratios

    The PE ratio is -1.41 and the forward PE ratio is -14.14. Iterum Therapeutics's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.41

    Forward PE

    n/a
    		 -14.14

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 -8.54

    P/FCF Ratio

    n/a
    		 -1.3

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Iterum Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.41, with a Debt / Equity ratio of -11.16.

    Current Ratio

    n/a
    		 1.41

    Quick Ratio

    n/a
    		 1.41

    Debt / Equity

    n/a
    		 -11.16

    Debt / EBITDA

    n/a
    		 -2.44

    Debt / FCF

    n/a
    		 -1.7

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,752,666.67

    Employee Count

    n/a
    		 9

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 240K

    Effective Tax Rate

    n/a
    		 -0.98%

    Stock Price Statistics

    The stock price has increased by -13.39% in the last 52 weeks. The beta is 2.82, so Iterum Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.82

    52-Week Price Change

    n/a
    		 -13.39%

    50-Day Moving Average

    n/a
    		 1.02

    200-Day Moving Average

    n/a
    		 1.34

    Relative Strength Index (RSI)

    n/a
    		 45.04

    Average Volume (20 Days)

    n/a
    		 528,708

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -254K

    Operating Income

    n/a
    		 -18.7M

    Net Income

    n/a
    		 -24.77M

    EBITDA

    n/a
    		 -18.7M

    EBIT

    n/a
    		 -27.06M

    Earnings Per Share (EPS)

    n/a
    		 -1.26
    Full Income Statement

    Balance Sheet

    The company has 24.13M in cash and 45.53M in debt, giving a net cash position of -21.41M.

    Cash & Cash Equivalents

    n/a
    		 24.13M

    Total Debt

    n/a
    		 45.53M

    Net Cash

    n/a
    		 -21.41M

    Retained Earnings

    n/a
    		 -486.07M

    Total Assets

    n/a
    		 32.98M

    Working Capital

    n/a
    		 9.88M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -26.77M and capital expenditures -2K, giving a free cash flow of -26.77M.

    Operating Cash Flow

    n/a
    		 -26.77M

    Capital Expenditures

    n/a
    		 -2K

    Free Cash Flow

    n/a
    		 -26.77M

    FCF Per Share

    n/a
    		 -1.36
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ITRM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ITRM is $9, which is 827.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 827.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 18, 2022. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Aug 18, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -21.4

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist